title: Prospective comparison of sodium hyaluronate and hylan G-F 20 in a clinical practice: comment on the concise communication by Martens.
authors.forename: Daniel J
authors.initials: DJ
authors.lastname: Brown
authors.forename: Edward V
authors.initials: EV
authors.lastname: Wood
authors.forename: Hayley M
authors.initials: HM
authors.lastname: Hannah
authors.forename: Vadlamani S
authors.initials: VS
authors.lastname: Rao
authors.forename: David
authors.initials: D
authors.lastname: Teanby
mesh_terms: D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D006820:Hyaluronic Acid / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D020370:Osteoarthritis, Knee / Q000188:drug therapy*; D011446:Prospective Studies
chemical_list: D000276:Adjuvants, Immunologic; C049816:hylan; D006820:Hyaluronic Acid